US Exempts India and 19 Countries from Tariffs on Select Specialty Drugs
The US Commerce Department has exempted certain speciality drugs and their ingredients imported from India and 19 other countries from a 100 per cent tariff set to take effect on September 29. The zero tariff applies to medicines for rare diseases, infertility, cell and gene therapies, antibody-drug conjugates, and animal pharmaceuticals. This exemption is part of implementing President Trump's April proclamation under Section 232 of the Trade Expansion Act, aimed at encouraging domestic pharmaceutical production while allowing critical specialty drugs duty-free entry from countries with trade or security agreements with the US.
First-hand measurement across 15 sources
We measured how 15 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (52/100). Lens Score 43/100.
Outlets measured: thefinancialexpress, timesnow, businessstandard, republicworld, indianexpress, economictimes, businessstandard, wion, and 7 more. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–65/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
freepressjournal broke this story on 28 Sept, 06:03 pm. Other outlets followed.